Table 3 Reasons for treatment failure and secondary outcomes.
From: A trial comparing continuous positive airway pressure (CPAP) devices in preterm infants
Outcome | Seattle-PAP (n = 112) | FP-CPAP (n = 120) | Risk Difference (95% CI) | P value |
---|---|---|---|---|
Reason for treatment failurea | ||||
Failure of successful transitionb | 15 (13.4) | 18 (15.0) | −1.6 (−10.6–7.4) | 0.73 |
Increase in fraction of inspired oxygen | 15 (13.4) | 22 (18.3) | −4.9 (−14.3–4.4) | 0.30 |
Escalation of respiratory care requiring intubationc | 22 (19.6) | 24 (20.0) | −0.4 (−10.6–9.9) | 0.95 |
Escalation of respiratory care to SiPAP | 3 (2.7) | 0 (0) | 2.7 (−0.3–5.7) | 0.11 |
Number of days on mechanical ventilation after trial entry, median (IQR)d | 0 (0–4) | 0 (0–5) | NA | 0.20 |
Number of days any positive pressure support after trial entry, median (IQR)e,f | 47.5 (34.5–75.5) | 51 (32–74) | NA | 0.99 |
Number of days of oxygen therapy after trial entry, median (IQR)f | 28.5 (5–91) | 34 (5–84) | NA | 0.63 |
Number of days on room air after trial entry, median (IQR)f | 46 (19–57) | 43 (20–60) | NA | 0.93 |
Number of days to achieve full enteral feeding after trial entry, median (IQR)f,g | 12.5 (10–14) | 11 (10–14) | NA | 0.73 |
Number of days to achieve full-suck feeding, median (IQR)f | 73 (63–80) | 78 (66–83) | NA | 0.95 |
Weight at discharge (kg)f | 3.1 (2.6–3.8) | 3.0 (2.6–4.1) | NA | 0.89 |